Rights Offering Decision, Allocation Ratio of 0.155 Shares per Share

Penetrium Bioscience announces a rights offering: issuance of common shares, allocation of 0.1551578144 shares per existing share (discount rate 25%)
Issue price calculation: based on weighted average prices (1-month, 1-week, base date) with a 25% discount, the lower of the 1st and 2nd issue prices is determined
Subscription schedule: existing shareholders July 9-10, 2026; public offering July 14-15, 2026 (lead manager: Yuanta Securities)
Use of proceeds: not disclosed (fields for facility, operating, etc. left blank)
Subscription rights certificates to be listed (June 24-30, 2026)